Enanta Pharmaceuticals, Inc.
NASDAQ:ENTA · NASDAQ Global Select
-$0.09 today
Vol 0.25M · Avg 0.17M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+77.81%
Period High
$16.85
Period Low
$6.49
Latest
$12.66
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Assembly Biosciences, Inc.
NASDAQ:ASMB
$386.75M
Atea Pharmaceuticals, Inc.
NASDAQ:AVIR
$345.32M
Prelude Therapeutics Incorporated
NASDAQ:PRLD
$331.65M
Nautilus Biotechnology, Inc.
NASDAQ:NAUT
$283.11M
Foghorn Therapeutics Inc.
NASDAQ:FHTX
$243.08M
Voyager Therapeutics, Inc.
NASDAQ:VYGR
$224.47M
Caribou Biosciences, Inc.
NASDAQ:CRBU
$158.51M
Immuneering Corporation
NASDAQ:IMRX
$157.01M
Pyxis Oncology, Inc.
NASDAQ:PYXS
$127.03M
Tenaya Therapeutics, Inc.
NASDAQ:TNYA
$116.44M
What is the latest ENTA filing?
The latest filing shown is 8-K dated Jun 18, 2026.
How many recent filings does ENTA have?
Intrinsic Alpha currently shows 20 recent filings for ENTA.
Explore More
Continue the stock analysis
Jump to another research area for this company.